|

Cyclophosphamide and fludarabine Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Tongji Hospital1

Indications

  • POEMS Syndrome1
  • Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)1
  • Idiopathic Inflammatory Myopathies1
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy1
  • Autoimmune Encephalitis1

Other1 trial

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.